Literature DB >> 8702983

Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts.

M J Thomas1, Y Umayahara, H Shu, M Centrella, P Rotwein, T L McCarthy.   

Abstract

Insulin-like growth factor-I (IGF-I), a multifunctional growth factor, plays a key role in skeletal growth and can enhance bone cell replication and differentiation. We previously showed that prostaglandin E2 (PGE2) and other agents that increase cAMP activated IGF-I gene transcription in primary rat osteoblast cultures through promoter 1 (P1), the major IGF-I promoter, and found that transcriptional induction was mediated by protein kinase A. We now have identified a short segment of P1 that is essential for full hormonal regulation and have characterized inducible DNA-protein interactions involving this site. Transient transfections of IGF-I P1 reporter genes into primary rat osteoblasts showed that the 328-base pair untranslated region of exon 1 was required for a full 5.3-fold response to PGE2; mutation in a previously footprinted site, HS3D (base pairs +193 to +215), reduced induction by 65%. PGE2 stimulated nuclear protein binding to HS3D. Binding, as determined by gel mobility shift assay, was not seen in nuclear extracts from untreated osteoblast cultures, was detected within 2 h of PGE2 treatment, and was maximal by 4 h. This DNA-protein interaction was not observed in cytoplasmic extracts from PGE2-treated cultures, indicating nuclear localization of the protein kinase A-activated factor(s). Activation of this factor was not blocked by cycloheximide (Chx), and Chx did not impair stimulation of IGF-I gene expression by PGE2. In contrast, binding to a consensus cAMP response element (CRE; 5'-TGACGTCA-3') from the rat somatostatin gene was not modulated by PGE2 or Chx. Competition gel mobility shift analysis using mutated DNA probes identified 5'-CGCAATCG-3' as the minimal sequence needed for inducible binding. All modified IGF-I P1 promoterreporter genes with mutations within this CRE sequence also showed a diminished functional response to PGE2. These results identify the CRE within the 5'-untranslated region of IGF-I exon 1 that is required for hormonal activation of IGF-I gene transcription by cAMP in osteoblasts.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  1996        PMID: 8702983     DOI: 10.1074/jbc.271.36.21835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A polymorphism of the CC16 gene is associated with an increased risk of asthma.

Authors:  I A Laing; J Goldblatt; E Eber; C M Hayden; P J Rye; N A Gibson; L J Palmer; P R Burton; P N Le Souëf
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

2.  Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.

Authors:  Bernhard Svejda; Mark Kidd; Andrew Timberlake; Kathy Harry; Alexander Kazberouk; Simon Schimmack; Ben Lawrence; Roswitha Pfragner; Irvin M Modlin
Journal:  Cancer Sci       Date:  2013-05-24       Impact factor: 6.716

3.  Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts.

Authors:  Thomas L McCarthy; Zhong Yun; Joseph A Madri; Michael Centrella
Journal:  Gene       Date:  2014-01-15       Impact factor: 3.688

4.  Loss of CD73-mediated extracellular adenosine production exacerbates inflammation and abnormal alveolar development in newborn mice exposed to prolonged hyperoxia.

Authors:  Huiling Li; Harry Karmouty-Quintana; Ning-Yuan Chen; Tingting Mills; Jose Molina; Michael R Blackburn; Jonathan Davies
Journal:  Pediatr Res       Date:  2017-08-23       Impact factor: 3.756

5.  GATA depletion impacts insulin-like growth factor 1 mRNA and protein levels in luteinizing porcine granulosa cells.

Authors:  Holly A LaVoie; Richard J Kordus; Jonathan B Nguyen; Jeremy L Barth; Yvonne Y Hui
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

6.  Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts.

Authors:  Jason L S Leen; Angelo Izzo; Chandani Upadhyay; Katherine J Rowland; Philip E Dubé; Steven Gu; Scott P Heximer; Christopher J Rhodes; Daniel R Storm; P Kay Lund; Patricia L Brubaker
Journal:  Endocrinology       Date:  2010-12-15       Impact factor: 4.736

7.  Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.

Authors:  Zonggao Shi; Maria J Henwood; Peter Bannerman; Dalia Batista; Anelia Horvath; Marta Guttenberg; Constantine A Stratakis; Adda Grimberg
Journal:  Growth Horm IGF Res       Date:  2007-02-05       Impact factor: 2.372

8.  PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.

Authors:  Arnulfo Quesada; Becky Y Lee; Paul E Micevych
Journal:  Dev Neurobiol       Date:  2008-04       Impact factor: 3.964

9.  IGF-1 receptor-mediated ERK/MAPK signaling couples status epilepticus to progenitor cell proliferation in the subgranular layer of the dentate gyrus.

Authors:  Yun-Sik Choi; Hee-Yeon Cho; Kari R Hoyt; Janice R Naegele; Karl Obrietan
Journal:  Glia       Date:  2008-05       Impact factor: 7.452

Review 10.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.